Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United States

Authors:
  • WCWilliam E. Cunningham
    William E. Cunningham
  • LMLeona E. Markson
    Leona E. Markson
  • RARonald M. Andersen
    Ronald M. Andersen
  • SCStephen H. Crystal
    Stephen H. Crystal
  • JFJohn A. Fleishman
    John A. Fleishman
  • CGCarol Golin
    Carol Golin
  • AGAllen Gifford
    Allen Gifford
  • HLHonghu H. Liu
    Honghu H. Liu
  • TNTerry T. Nakazono
    Terry T. Nakazono
  • SMSally Morton
    Sally Morton
  • SBSamuel A. Bozzette
    Samuel A. Bozzette
  • MSMartin F. Shapiro
    Martin F. Shapiro

Abstract
Incidence of opportunistic protozoal infections causing diarrheal illnesses in patients with HIV has decreased since the introduction of highly active antiretroviral therapy (HAART). The objective of this study was to determine whether the parasites, cryptosporidia, and microsporidia were effectively eradicated or only suppressed following treatment. Six HIV-positive patients with diarrheal symptoms caused by cryptosporidia or microsporidia were prospectively followed up with stool samples and duodenal biopsies. Samples were taken before HAART, between 1 to 3 months, and 6 months post-HAART. Duodenal samples were analyzed using routine histology and transmission electron microscopy. Stool samples were analyzed by both light microscopy and polymerase chain reaction (PCR) techniques. Patients who responded successfully to HAART eradicated both cryptosporidial and microsporidial organisms. Symptoms improved within 1 month of therapy but complete eradication of the organisms was only observed after 6 months of treatment. AIDs-related cryptosporidiosis and microsporidiosis can be cured following successful antiretroviral therapy.